Exagen Operating Income 2011-2026 | XGN

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Exagen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-14.1 M	-13.6 M	-22.8 M	-46.1 M	-24.1 M	-15.2 M	-9.3 M	-4.88 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-4.88 M	-46.1 M	-18.8 M

Quarterly Operating Income Exagen

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-3.1 M	-2.63 M	-3.36 M	-	-4.66 M	-2.59 M	-3 M	-	-5.07 M	-4.92 M	-7.71 M	-	-7.82 M	-14.1 M	-9.68 M	-	-6.5 M	-5.74 M	-5.57 M	-	-3.79 M	-3.42 M	-5.22 M	-	-2.16 M	-2.41 M	-1.87 M	-	-1.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-1.13 M	-14.1 M	-4.84 M

Operating Income of other stocks in the Diagnostics research industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-46 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	-28.1 M	-	-17.87 %	$ 25.9 M	Canada
Bioventus BVS	54 M	$ 8.98	1.18 %	$ 598 M	USA
Brainsway Ltd. BWAY	-5 M	$ 13.87	1.61 %	$ 99.4 M	Israel
Castle Biosciences CSTL	8.67 M	$ 26.0	0.64 %	$ 722 M	USA
Aspira Women's Health AWH	-32.8 M	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	912 M	$ 68.09	2.64 %	$ 26.6 B	USA
Guardant Health GH	-437 M	$ 88.7	1.74 %	$ 11.1 B	USA
Charles River Laboratories International CRL	25.2 M	$ 155.4	2.26 %	$ 7.7 B	USA
CareDx, Inc CDNA	-30.8 M	$ 17.57	1.44 %	$ 936 M	USA
ICON Public Limited Company ICLR	1.1 B	$ 101.48	3.96 %	$ 8.37 B	Irlanda
IQVIA Holdings IQV	2.18 B	$ 169.45	2.77 %	$ 29.1 B	USA
Accelerate Diagnostics AXDX	-14 M	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	-206 M	$ 103.94	0.08 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	609 M	-	-	$ 399 M	China
Genetron Holdings Limited GTH	-518 M	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	-73.9 M	$ 15.65	4.65 %	$ 473 M	USA
Biodesix BDSX	-34.5 M	$ 17.5	1.21 %	$ 2.27 B	USA
Anixa Biosciences ANIX	-11.7 M	$ 2.88	1.23 %	$ 93.5 K	USA
Neogen Corporation NEOG	-1.06 B	$ 9.37	2.85 %	$ 2.03 B	USA
Danaher Corporation DHR	4.69 B	$ 194.76	1.76 %	$ 139 B	USA
Biocept BIOC	-32 M	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	-20.3 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-20.8 M	-	-20.0 %	$ 1.06 M	USA
Pacific Biosciences of California PACB	-554 M	$ 1.4	3.16 %	$ 420 M	USA
Illumina ILMN	-833 M	$ 121.73	2.05 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	1.56 B	$ 199.39	0.23 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	97.7 M	-	-	$ 10.6 B	Niderland
Agilent Technologies A	1.35 B	$ 113.69	1.66 %	$ 34.6 B	USA
BioNano Genomics BNGO	-104 M	$ 1.12	0.9 %	$ 1.42 M	USA
DarioHealth Corp. DRIO	-56.2 M	$ 9.28	10.24 %	$ 263 M	Israel
Lantheus Holdings LNTH	311 M	$ 78.71	0.26 %	$ 5.31 B	USA
Chembio Diagnostics CEMI	-23.6 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-25.9 M	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	-42.7 M	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	535 M	$ 457.78	0.91 %	$ 13.2 B	USA
Motus GI Holdings MOTS	-11.9 M	-	-34.28 %	$ 263 K	Israel
Celcuity CELC	-113 M	$ 114.64	-0.23 %	$ 4.52 B	USA
DermTech DMTK	-104 M	-	-11.32 %	$ 2.94 M	USA
Twist Bioscience Corporation TWST	-136 M	$ 46.28	2.82 %	$ 2.77 B	USA
National Research Corporation NRC	22.6 M	$ 18.07	3.85 %	$ 404 M	USA
NeoGenomics NEO	-116 M	$ 8.41	2.06 %	$ 1.08 B	USA
Invitae Corporation NVTA	-94.9 M	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	-12.4 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	-541 M	$ 201.38	1.87 %	$ 19.8 B	USA